Product Program year 2020 Source: CMS Open Payments

Olympus EBUS Bronchoscopes

Device GI & Respiratory Products

Open in the dashboard

General payments

$612,459

1,497 payments

Research payments

$27,083

2 payments

Through program year 2020, $612,459 in general payments and $27,083 in research payments were reported against Olympus EBUS Bronchoscopes (GI & Respiratory Products).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $57,437 204
2020 Research $27,083 2
2019 General $555,022 1,293

Breakdown

Who paid General payments · program years 2019–2020
  1. Olympus Corporation of the Americas $582,318 1,468 payments
  2. Olympus America Inc. $22,486 19 payments
  3. Olympus Latin America, Inc. $7,654 10 payments
Top recipients General payments · program year 2020
  1. Alexander Chen Pulmonary Disease · Saint Louis, MO $13,420 23% · 21 payments
  2. Momen Wahidi Pulmonary Disease · Chicago, IL $10,964 19% · 21 payments
  3. Michael MacHuzak Pulmonary Disease · Cleveland, OH $10,380 18% · 15 payments
  4. Robert Kruklitis Critical Care Medicine · Allentown, PA $5,807 10% · 13 payments
  5. Ali Moghani Lankarani Gastroenterology · Jacksonville, FL $4,200 7% · 2 payments

The top 5 of 33 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pulmonary Disease Internal Medicine $41,536 75% · 22 practitioners
  2. Critical Care Medicine Internal Medicine $7,598 14% · 5 practitioners
  3. Gastroenterology Internal Medicine $4,200 8% · 1 practitioner
  4. Internal Medicine $1,291 2% · 2 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $498 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Missouri $13,420 23% · 1 recipient
  2. North Carolina $12,110 21% · 3 recipients
  3. Ohio $10,933 19% · 3 recipients
  4. Pennsylvania $6,286 11% · 3 recipients
  5. Florida $4,622 8% · 2 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,497 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record